Northern California Hematology Oncology Conference: A Tumor Board Case-Based Approach to the Latest Breakthroughs
The Northern California Hematology Oncology Conference: A Tumor Board Case-Based Approach to the Latest Breakthroughs is a CME-accredited, in-person hematology oncology conference designed to improve the care of cancer patients by educating clinicians involved in cancer care.
The expert faculty will present a comprehensive overview of recent updates in hematology and oncology. The program will feature in-depth discussions and analyses of the latest scientific discoveries and advancements. Faculty will contextualize these findings within clinical practice and explore their potential to alter current standards of care. This conference is designed for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals, providing them with the latest updates in the field. Emphasizing a multidisciplinary approach, it will showcase the integration of new advancements into patient-centered care.
Target Audience
Hematologists, Oncologists
Surgeons
Radiation Oncologists
Physician Assistants/Nurse Practitioners
Pharmacists
Nurses
Organizing Committee
Conference Director:
Binay Shah, MD, MHA - Binaytara Foundation
Conference Chair:
Deepti Behl, MD - Sutter Health
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Review recent updates and discuss their applications in clinical settings.
- Choose new therapeutic options for treating benign and malignant hematologic disorders and solid tumors, understanding appropriate indications and contraindications to these therapeutic approaches.
- Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in the standards of care in hematology and oncology.
- Integrate evolving diagnostic, prognostic, and therapeutic approaches to managing hematologic disorders and oncology patients.
- Individualize management of patients based on emerging data from clinical trials and evolving expert guidelines.
Hotel Room Reservation
A limited number of guestrooms are reserved at the Double Tree Sacramento for the participants of this meeting at a discounted rate of $149 per night. The room rate does not include any additional fees or applicable taxes.
CUTOFF - Friday, December 20, 2024
Parking
Guests will receive discounted hotel parking at $5 per day
DAY 1 - FRIDAY, JANUARY 10th, 2025
All times are listed in Pacific Time (PT)
02:00 PM – 03:00 PM Registration, Networking, & Exhibits
03:00 PM – 03:15 PM Welcome & Opening Remarks
03:15 PM – 04:45 PM Session 1: Hematologic Malignancies: Case-Based Discussion
Session Chair: Rajesh Behl, MD
03:15 PM – 03:35 PM MDS/Acute Leukemia - Brian Andrew Jonas, MD, PhD, FACP
03:35 PM – 03:55 PM Lymphoma/CLL - Aaron Goodman, MD
03:55 PM – 04:15 PM Multiple Myeloma - Alfred Chung, MD
04:15 PM - 04:45 PM Panel Discussion
04:45 PM – 05:30 PM Session 2: Changing Landscapes in Oncology - Liquid Biopsy
04:45 PM - 05:15 PM Keynote Speech: Updates in Liquid Biopsy - Matthew Gubens, MD, MS, FASCO
05:15 PM - 05:30 PM Q&A Session
05:30 PM – 06:30 PM Reception, Networking, & Exhibits
DAY 2 - SATURDAY, JANUARY 11th, 2025
07:00 AM – 08:00 AM Registration, Breakfast & Exhibits
08:00 AM – 08:05 AM Welcome
08:05 AM – 08:25 AM Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD
08:25 AM – 09:40 AM Session 3: Thoracic Oncology: Case-Based Discussion
Session Chair: Hubert Pan, MD & Vijay Suhag, MD
08:25 AM – 08:45 AM Early-Stage Lung Cancer - Tianhong Li, MD, PhD
08:45 AM – 09:05 AM Advanced Lung Cancer - Rafael Santana-Davila, MD
09:05 AM – 09:25 AM Small Cell Lung Cancer - Hatim Husain, MD
09:25 AM - 09:40 AM Panel Discussion
09:40 AM – 10:00 AM Break & Exhibits
10:00 AM – 11:30 AM Session 4: Genitourinary Cancer: Case-Based Discussion
Session Chair: Seth Rosenthal, MD, FACR, FASTRO
10:00 AM – 10:20 AM Kidney Cancer - Mamta Parikh, MD, MS
10:20 AM – 10:40 AM Prostate Cancer -
10:40 AM – 11:00 AM Bladder Cancer - Nitin Rohatgi, MD
11:00 AM - 11:30 AM Panel Discussion
11:30 AM – 12:30 PM Session 5: Challenging Cases
Session Chair: Yelena Krijanovski, MD
11:30 AM – 11:45 AM Melanoma - Kevin Kim, MD
11:45 AM – 12:00 PM Sarcoma - Varun Monga, MBBS
12:00 PM – 12:15 PM Head and Neck Cancer - Mohammad Hararah, MD, MPH
12:15 PM – 12:30 PM Panel Discussion
12:30 PM – 01:30 PM Lunch & Exhibits
01:30 PM – 02:30 PM Session 6: Metastatic Breast Cancer: Case-Based Discussion
Session Chair: Sareena Malhi, MD
01:30 PM – 01:50 PM Metastatic Breast Cancer 1 (Hormone Receptor Positive) - Kristie Bobolis, MD
01:50 PM – 02:10 PM Metastatic Breast Cancer 2 (HER2+ and Triple-Negative Breast Cancer) -
02:10 PM - 02:30 PM Panel Discussion
02:30 PM – 03:30 PM Session 7: GI Cancer: Case-Based Discussion
Session Chair: Dron Gauchan, MD & Jasdeepa Nagi, MD
02:30 PM – 02:50 PM Upper GI Malignancies - Daneng Li, MD
02:50 PM – 03:10 PM Lower GI Malignancies - Thorvardur Halfdanarson, MD
03:10 PM - 03:30 PM Panel Discussion
03:30 PM Adjourn
Hotel Room Reservation
A limited number of guestrooms are reserved at the Double Tree Sacramento for the participants of this meeting at a discounted rate of $149 per night. The room rate does not include any additional fees or applicable taxes.
CUTOFF - Friday, December 20, 2024
Parking
Guests will receive discounted hotel parking at $5 per day
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Binay Shah, MD, MHA
DEEPTI BEHL, M.D.
Dron Gauchan
Sareena Malhi
Hubert Pan, MD
Matthew Gubens
Alfred Chung, Assistant Professor
Tianhong Li, M.D., Ph.D.
Varun Monga
Mamta Parikh, MD,MS
Nitin Rohatgi
Rafael Santana-Davila, MD
Acknowledgement of Commercial Support
This activity is supported with an Independent Medical Education Grant from Janssen Biotech, Inc.
Available Credit
- 8.25 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 8.25 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 8.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 8.25 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 8.25 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.